Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys

Journal of Clinical Investigation

Volumn 119, Issue 12, 2009, Pages 3556-3572

  Bosinger, Steven E ^a,b   Li, Qingsheng ^c   Gordon, Shari N ^a   Klatt, Nichole R ^a   Duan, Lijie ^c   Xu, Luoling ^b   Francella, Nicholas ^a   Sidahmed, Abubaker ^b   Smith, Anthony J ^c   Cramer, Elizabeth M ^a   Zeng, Ming ^c   Masopust, David ^c   Carlis, John V ^d   Ran, Longsi ^b   Vanderford, Thomas H ^a   Paiardini, Mirko ^a   Isett, R Benjamin ^a   Baldwin, Don A ^a   Else, James G ^e   Staprans, Silvija I ^f   Silvestri, Guido ^a,e   Haase, Ashley T ^c,d   Kelvin, David J ^b,g,h   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e EMORY UNIVERSITY   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

^g SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^h NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CERCOCEBUS; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; IMMUNOREGULATION; INNATE IMMUNITY; LYMPH NODE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SYSTEMS BIOLOGY; UPREGULATION; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CERCOCEBUS ATYS; GENOME-WIDE ASSOCIATION STUDY; IMMUNITY, INNATE; INTERFERONS; MACACA MULATTA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES SPECIFICITY; UP-REGULATION;

EID: 72849132344     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI40115     Document Type: Article

References (77)

1. Picker, L.J. 2006. Immunopathogenesis of acute AIDS virus infection. Curr. Opin. Immunol. 18:399-405. (Pubitemid 43947575)
2. Mellors, J.W., et al. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1167-1170.
3. Douek, D.C., Roederer, M., and Koup, R.A. 2009. Emerging concepts in the immunopathogenesis of AIDS. Annu. Rev. Med. 60:471-484.
4. Sodora, D.L., and Silvestri, G. 2008. Immune activation and AIDS pathogenesis. AIDS. 22:439-446.
5. Aziz, N., et al. 1999. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. J. Infect. Dis. 179:843-848. (Pubitemid 29159329)
6. De Boer, R.J., Mohri, H., Ho, D.D., and Perelson, A.S. 2003. Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques. J. Immunol. 170:2479-2487. (Pubitemid 36245637)
7. Hellerstein, M., et al. 1999. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 5:83-89.
8. Picker, L.J., et al. 2004. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J. Exp. Med. 200:1299-1314.
9. Deeks, S.G., et al. 2004. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood. 104:942-947.
10. Leng, Q., et al. 2001. Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection. J. Acquir. Immune Defic. Syndr. 27:389-397. (Pubitemid 32729086)
11. Sousa, A.E., et al. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169:3400-3406.
12. Giorgi, J.V., et al. 2002. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J. Acquir. Immune Defic. Syndr. 29:346-355.
13. Hazenberg, M.D., et al. 2003. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 17:1881-1888.
14. Giorgi, J.V., et al. 1999. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179:859-870.
15. Paiardini, M., Pandrea, I., Apetrei, C., and Silvestri, G. 2009. Lessons Learned from the Natural Hosts of HIV-Related Viruses. Annu. Rev. Med. 60:485-495.
16. Hahn, B.H., Shaw, G.M., De Cock, K.M., and Sharp, P.M. 2000. AIDS as a zoonosis: scientific and public health implications. Science. 287:607-614. (Pubitemid 30070900)
17. Dunham, R., et al. 2006. The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood. 108:209-217.
18. Gordon, S.N., et al. 2007. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J. Immunol. 179:3026-3034.
19. Gordon, S.N., et al. 2008. Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesis. J. Virol. 82:3725-3735.
20. Klatt, N.R., et al. 2008. Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys. J. Clin. Invest. 118:2039-2049.
21. Rey-Cuille, M.A., et al. 1998. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J. Virol. 72:3872-3886.
22. Silvestri, G., et al. 2003. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic highlevel viremia. Immunity. 18:441-452. (Pubitemid 36351522)
23. Silvestri, G., et al. 2007. Understanding the benign nature of SIV infection in natural hosts. J. Clin. Invest. 117:3148-3154. (Pubitemid 350096967)
24. Schindler, M., et al. 2006. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell. 125:1055-1067.
25. Schindler, M., et al. 2008. Inefficient Nef-mediated downmodulation of CD3 and MHC-I correlates with loss of CD4+T cells in natural SIV infection. PLoS Pathog. 4:e1000107.
26. Brenchley, J.M., et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:1365-1371.
27. Pandrea, I., et al. 2007. Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts. Blood. 109:1069-1076.
28. Estes, J.D., et al. 2008. Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques. J. Immunol. 180:6798-6807.
29. Mandl, J.N., et al. 2008. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat. Med. 14:1077-1087.
30. Silvestri, G., et al. 2005. Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J. Virol. 79:4043-4054. (Pubitemid 40388344)
31. Meythaler, M., et al. 2009. Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection. J. Virol. 83:572-583.
32. Muthukumar, A., et al. 2005. Timely triggering of homeostatic mechanisms involved in the regulation of T-cell levels in SIVsm-infected sooty mangabeys. Blood. 106:3839-3845. (Pubitemid 41739021)
33. Dennis, G., Jr., et al. 2003. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 4:P3.
34. Yoneyama, M., et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNAinduced innate antiviral responses. Nat. Immunol. 5:730-737. (Pubitemid 39023305)
35. Kawai, T., et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988. (Pubitemid 41486182)
36. Freeman, G.J., et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:1027-1034.
37. Mellor, A.L., and Munn, D.H. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4:762-774.
38. Cerdan, C., Devilard, E., Xerri, L., and Olive, D. 2001. The C-class chemokine lymphotactin costimulates the apoptosis of human CD4(+) T cells. Blood. 97:2205-2212. (Pubitemid 32291464)
39. Schreiber, V., Dantzer, F., Ame, J.C., and de Murcia, G. 2006. Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell Biol. 7:517-528. (Pubitemid 44036457)
40. Zhang, N., Hopkins, K., and He, Y.W. 2008. c-FLIP protects mature T lymphocytes from TCR-mediated killing. J. Immunol. 181:5368-5373.
41. Kovaleski, B.J., et al. 2006. In vitro characterization of the interaction between HIV-1 gag and human lysyltRNA synthetase. J. Biol. Chem. 281:19449-19456.
42. Neil, S.J., Zang, T., and Bieniasz, P.D. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 451:425-430. (Pubitemid 351158893)
43. Van Damme, N., et al. 2008. The interferoninduced protein BST-2/CD317 restricts release of virions from infected cells and is down-regulated from the cell surface by HIV-1 Vpu. Cell Host Microbe. 3:245-252.
44. Sadler, A.J., and Williams, B.R. 2008. Interferoninducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
45. Hardy, G.A., et al. 2009. Desensitization to type I interferon in HIV-1 infection correlates with mark ers of immune activation and disease progression. Blood. 113:5497-5505.
46. Embretson, J., et al. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 362:359-362. (Pubitemid 23101311)
47. Pantaleo, G., et al. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 362:355-358. (Pubitemid 23101310)
48. Reimann, K.A., et al. 1994. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68:2362-2370. (Pubitemid 24091915)
49. Li, Q., et al. 2009. Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection. J. Immunol. 183:1975-1982.
50. Ganz, T. 2002. Immunology. Versatile defensins. Science. 298:977-979.
51. Douek, D.C. 2003. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev. 5:172-177.
52. Querec, T.D., et al. 2009. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10:116-125.
53. Wherry, E.J., et al. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 27:670-684.
54. Pandrea, I.V., et al. 2007. Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J. Immunol. 179:3035-3046.
55. Cumont, M.C., et al. 2008. Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J. Virol. 82:1175-1184.
56. Diop, O.M., et al. 2008. Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome. J. Virol. 82:5145-5152.
57. Kaur, A., et al. 1998. Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J. Virol. 72:9597-9611. (Pubitemid 28520823)
58. Jacquelin, B., et al. 2009. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Invest. 119:3544-3555.
59. Lederer, S., et al. 2009. Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLoS Pathog. 5:e1000296.
60. Hyrcza, M.D., et al. 2007. Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. J. Virol. 81:3477-3486.
61. Sedaghat, A.R., et al. 2008. Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferonmediated disruption of T-cell dynamics. J. Virol. 82:1870-1883.
62. Essers, M.A., et al. 2009. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature. 458:904-908.
63. Boasso, A., and Shearer, G.M. 2007. How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. Curr. Drug Metab. 8:217-223. (Pubitemid 46628287)
64. Hartner, J.C., Walkley, C.R., Lu, J., and Orkin, S.H. 2009. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat. Immunol. 10:109-115.
65. Jones, R.B., et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205:2763-2779.
66. Chawla-Sarkar, M., et al. 2003. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis. 8:237-249. (Pubitemid 36749609)
67. Carthagena, L., et al. 2009. Human TRIM gene expression in response to interferons. PLoS ONE. 4:e4894.
68. Rajsbaum, R., Stoye, J.P., and O'Garra, A. 2008. Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. Eur. J. Immunol. 38:619-630.
69. Peng, G., et al. 2006. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 203:41-46. (Pubitemid 43187928)
70. Zhang, L., et al. 2002. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science. 298:995-1000.
71. Munk, C., et al. 2003. The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res. Hum. Retroviruses. 19:875-881. (Pubitemid 37338913)
72. Wang, W., et al. 2004. Activity of alpha- and theta-defensins against primary isolates of HIV-1. J. Immunol. 173:515-520. (Pubitemid 38797379)
73. Lederman, M.M., Penn-Nicholson, A., Cho, M., and Mosier, D. 2006. Biology of CCR5 and its role in HIV infection and treatment. JAMA. 296:815-826. (Pubitemid 44223105)
74. Leone, A., Picker, L.J., and Sodora, D.L. 2009. IL-2, IL-7 and IL-15 as immuno-modulators during SIV/HIV vaccination and treatment. Curr. HIV Res. 7:83-90.
75. Garber, D.A., et al. 2004. Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication. J. Clin. Invest. 113:836-845.
76. Li, Q., et al. 2005. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature. 434:1148-1152.
77. Li, Q., et al. 2004. Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy. J. Infect. Dis. 189:572-582. (Pubitemid 38270908)